| Code | CSB-RA554616A0HU |
| Size | US$210 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
| Application | Recommended Dilution |
|---|---|
| IHC | 1:50-1:200 |
Dynamin-1 plays a central role in synaptic vesicle recycling, where it mediates the scission of clathrin-coated vesicles from the plasma membrane during endocytosis. This GTPase is predominantly expressed in neurons and has become an important target for researchers investigating synaptic transmission, neurological disorders, and the molecular mechanisms underlying vesicle trafficking. Dysregulation of DNM1 has been implicated in epileptic encephalopathies and other neurological conditions, making it a valuable marker for both basic neuroscience and translational research.
This recombinant monoclonal antibody, generated against a synthetic peptide derived from human DNM1, offers the consistency and reproducibility that demanding experimental workflows require. As a sequence-defined recombinant clone, it eliminates the lot-to-lot variability often encountered with traditional hybridoma-derived antibodies, ensuring that your results remain comparable across extended studies and collaborative projects.
The antibody has been validated for immunohistochemistry applications, with demonstrated performance in paraffin-embedded human brain tissue and human glioma samples. These validation studies, performed using citrate buffer antigen retrieval and HRP-polymer detection at 1:100 dilution, confirm reliable staining in both normal neural tissue and tumor specimens. The recommended working dilution range of 1:50 to 1:200 provides flexibility for optimization across different tissue preparations and detection systems.
For researchers exploring signal transduction pathways, synaptic function, or the role of endocytic machinery in disease states, this DNM1 antibody delivers the specificity and batch consistency needed for confident data generation in immunohistochemical analyses.
There are currently no reviews for this product.